These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 17669103

  • 1. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
    Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S.
    Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
    [Abstract] [Full Text] [Related]

  • 2. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
    Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A.
    Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
    [Abstract] [Full Text] [Related]

  • 3. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N, Park SH, Seo GS, Lee SW, Kim JW, Lee KJ, Shin WC, Kim TN, Park MI, Park JJ, Hong SJ, Shim KN, Kim SW, Shin YW, Chang YW, Chun HJ, Lee OJ, Jeon WJ, Park CG, Cho CM, Park CH, Won SY, Lee GH, Park KS, Shin JE, Kim HU, Park JY, Chae HS, Song GA, Kim JG, Yoon BC, Seol S, Jung HC, Chung IS.
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [Abstract] [Full Text] [Related]

  • 4. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
    Froehlich F, Gonvers JJ, Wietlisbach V, Burnand B, Hildebrand P, Schneider C, Saraga E, Beglinger C, Vader JP, Eradication in Dyspepsia (ERADYS) Study Group.
    Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
    [Abstract] [Full Text] [Related]

  • 5. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children.
    Hurduc V, Plesca D, Dragomir D, Sajin M, Vandenplas Y.
    Acta Paediatr; 2009 Jan; 98(1):127-31. PubMed ID: 18681892
    [Abstract] [Full Text] [Related]

  • 6. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
    Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, Song IS.
    Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY, Lee SW, Jung SW, Koo JS, Yim HJ, Park JJ, Chun HJ, Lee HS, Choi JH, Kim CD, Ryu HS.
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [Abstract] [Full Text] [Related]

  • 8. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
    Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA, Franceschi F, Cammarota G, Gasbarrini G, Gasbarrini A.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1181-8. PubMed ID: 15569121
    [Abstract] [Full Text] [Related]

  • 9. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H, Echizen H, Nachi S, Ohnishi A.
    Clin Pharmacol Ther; 2002 Jul 15; 72(1):33-43. PubMed ID: 12152002
    [Abstract] [Full Text] [Related]

  • 10. Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
    Oderda G, Marinello D, Lerro P, Kuvidi M, de'Angelis GL, Ferzetti A, Cucchiara S, Franco MT, Romano C, Strisciuglio P, Pensabene L.
    Helicobacter; 2004 Aug 15; 9(4):293-301. PubMed ID: 15270743
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
    Nguyen TV, Bengtsson C, Nguyen GK, Hoang TT, Phung DC, Sörberg M, Granström M.
    Helicobacter; 2008 Dec 15; 13(6):550-6. PubMed ID: 19166421
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A, Kadayifci A, Safali M, Ilgan S, Bagci S.
    J Dig Dis; 2007 Nov 15; 8(4):211-5. PubMed ID: 17970879
    [Abstract] [Full Text] [Related]

  • 13. The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori.
    Song MJ, Park DI, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI.
    Helicobacter; 2010 Jun 15; 15(3):206-13. PubMed ID: 20557362
    [Abstract] [Full Text] [Related]

  • 14. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
    Veldhuyzen van Zanten S, Fedorak RN, Lambert J, Cohen L, Vanjaka A.
    Am J Gastroenterol; 2003 Sep 15; 98(9):1963-9. PubMed ID: 14499772
    [Abstract] [Full Text] [Related]

  • 15. Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
    Cheng HC, Chang WL, Chen WY, Yang HB, Wu JJ, Sheu BS.
    Helicobacter; 2007 Aug 15; 12(4):359-63. PubMed ID: 17669110
    [Abstract] [Full Text] [Related]

  • 16. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.
    Myllyluoma E, Veijola L, Ahlroos T, Tynkkynen S, Kankuri E, Vapaatalo H, Rautelin H, Korpela R.
    Aliment Pharmacol Ther; 2005 May 15; 21(10):1263-72. PubMed ID: 15882248
    [Abstract] [Full Text] [Related]

  • 17. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K, Okimoto T, Kodama M, Sato R, Miyajima H, Ono M, Inoue K, Watanabe K, Otsu S, Fujioka T.
    Helicobacter; 2006 Oct 15; 11(5):436-40. PubMed ID: 16961805
    [Abstract] [Full Text] [Related]

  • 18. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
    Grgov S, Tasić T, Radovanović-Dinić B, Benedeto-Stojanov D.
    Vojnosanit Pregl; 2016 Nov 15; 73(11):1044-9. PubMed ID: 29328644
    [Abstract] [Full Text] [Related]

  • 19. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P, Iacopini F, Crispino P, Nardi F, Bella A, Rivera M, Rossi P, Gurnari M, Caracciolo F, Zippi M, Pica R.
    Helicobacter; 2006 Dec 15; 11(6):562-8. PubMed ID: 17083378
    [Abstract] [Full Text] [Related]

  • 20. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
    Kim BG, Lee DH, Ye BD, Lee KH, Kim BW, Kim SG, Kim SW, Kim SK, Kim JJ, Kim HY, Park JJ, Park CY, Baik GH, Lee YC, Lee JH, Lee JH, Chun HJ, Hahm KB, Hong SJ, Lee SW, Jung HC.
    Helicobacter; 2007 Feb 15; 12(1):31-5. PubMed ID: 17241298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.